Main content

Drug on the Market

In Global Business this week Peter Day hears from Dr. Andrea Pfeifer founder of a small biotech company in Switzerland looking for an effective treatment for Alzheimers disease.

Every 72 seconds a new patient is diagnosed with Alzheimer’s disease and it’s estimated by 2050 healthcare costs will be around $1 trillion, a big worry in a world with an ageing population. In this week’s Global Business Peter Day hears from Dr. Andrea Pfeifer of the Swiss biotech company, AC Immune and hears how this small company is making encouraging strides in it’s quest for effective treatments for Alzheimer’s Disease.

Available now

25 minutes

Last on

Sun 25 Jul 2010 18:05GMT

Broadcasts

  • Tue 20 Jul 2010 08:05GMT
  • Tue 20 Jul 2010 11:05GMT
  • Tue 20 Jul 2010 19:05GMT
  • Wed 21 Jul 2010 00:05GMT
  • Sat 24 Jul 2010 22:05GMT
  • Sun 25 Jul 2010 18:05GMT

Advice For Entrepreneurs

What is the one piece of advice successful global entrepreneurs would offer?

Download this programme

Subscribe to this programme or download individual episodes.